Purpose The aim of this study was to evaluate the effects of low-level laser therapy (LLLT) and antimicrobial photodynamic therapy (aPDT) as adjuvant to mechanical treatment of experimental periodontitis (EP) in adult rats submitted to 5-fluorouracil (5-FU) chemotherapy. Methods EP was induced through ligature around the left mandibular first molar for 7 days. The ligature was removed and the animals separated into groups: EP, no treatment; 5FU, systemic administration of 5-FU (80 and 40 mg/kg); 5FU/ scaling and root planing (SRP), systemic application of 5-FU and SRP; 5FU/SRP/LLLT, systemic application of 5-FU, SRP, and LLLT (660 nm, 0.035 W; 29.4 J/cm 2 ); and 5FU/ SRP/aPDT, systemic application of 5-FU, SRP, and aPDT (methylene blue irrigation and LLLT). The animals were euthanized 7, 15, and 30 days after treatments. Histological sections from mandibles were processed for histomorphometric and immunohistochemical analysis (TRAP, RANKL, OPG, TNF-α, IL-6, IL-10). The alveolar bone loss (BL) area in the furcation region of the mandibular first molar was analyzed histometrically. Results There was less bone loss in 5FU/SRP/aPDT compared with 5FU at 7 days (p < 0.05). The immunohistochemical analysis showed no significant difference for TRAP and osteoprotegerin, but lower RANKL immunolabeling was observed in the 5FU/SRP/LLLT and 5FU/SRP/aPDT groups compared with the 5FU group at 15 days. There was lower TNF-α and IL-6 immunolabeling in the 5FU/SRP/LLLT and 5FU/SRP/ aPDT groups and higher IL-10 immunolabeling in 5FU/SRP/ aPDT at 30 days. Conclusion LLLT and aPDT adjuvant to SRP minimized the effects of 5-FU on periodontal disease. Furthermore, aPDT promoted greater benefits in bone loss control and inflammatory response.
Introduction
Oncologic treatment consists of surgical therapy associated or not with sessions of radiotherapy and/or chemotherapy. Besides the systemic side effects due to immunosuppression, chemotherapy or radiotherapy may also cause undesirable effects in the buccal mucous membrane, such as mucositis, among others [1] . Through the years, chemotherapy has focused on inhibiting proliferation of neoplastic cells, although cancer is considered a disease with a relative deficiency of apoptosis, instead of an excess of cellular proliferation. Therefore, studies have analyzed the effects of the use of chemotherapeutic agents with apoptosis induction potential [2] , such as 5-fluorouracil (5-FU) [3] . This drug is indicated for treatment of solid malignant tumors in the gastrointestinal system, central nervous system, breast, and ovary [3] , interfering in the metabolism of nucleotides and incorporating into RNA and DNA, leading to cytotoxicity and cellular death [4] .
Periodontal diseases (PD) are caused by periodontopathogen microorganisms and influenced by local and systemic factors that can alter individual response in the face of microbial aggression [5] . Immune-inflammatory reactions are triggered in periodontal tissues as a way of preventing periodontopathogenic microorganisms or their toxins from spreading or invading the tissues [5] . These reactions constitute the host defense, which in some cases can be harmful, since they can alter or destroy cells in the connective tissue, besides inducing alveolar bone loss [5] . Bacterial infection increases the production of pro-inflammatory cytokines, such as tumoral necrosis factor alfa (TNF-α) and interleukins, besides inducing the production of other secondary mediators, such as chemokines and prostaglandins [6] . Previous clinical studies pointed out that patients submitted to chemotherapy with 5-FU showed increased gingival inflammation, plaque, and probing depth rate [7] [8] [9] [10] .
PD treatments involve mechanical removal of the buccal biofilm or maintenance of therapeutic concentrations of antimicrobials in the buccal cavity; however, both procedures present limitations [11, 12] . A recent study demonstrated that 5-FU aggravated periodontitis severity and compromised the host response to a conventional treatment in rats [13] , suggesting the necessity of adjuvant therapies.
Low-level laser therapy (LLLT) has been used for treatment and prevention of mucositis induced by chemotherapy, due to the capacity of reducing the severity of these buccal lesions [14] [15] [16] . Some in vivo studies evaluated the effects of LLLT as coadjuvant on conventional treatment of experimental periodontitis (EP) in animals with experimentally induced diabetes [17] , using immunosupressant drugs [18] , nicotine [19] , or estrogen suppression [20] . These studies demonstrated some advantages of LLLT, due to its benefits during the tissue repair process. A recent study demonstrated that LLLT is an adjuvant therapy that improves periodontal health in rats with EP under 5-FU chemotherapy [21] .
The antimicrobial photodynamic therapy (aPDT) for treatment of human infections is based on the concept that a photosensitizer agent can be absorbed by bacteria and activated by a light with specific wavelength in the presence of oxygen, producing chemical reactions that culminate in the formation of singlet oxygen or free radicals that are cytotoxic for microorganisms [11] . Nevertheless, there are no reports in the literature on the use of aPDT for periodontitis treatment during chemotherapy. Taken together, the purpose of the present study was to compare the effects of LLLT and aPDT, as coadjuvant to scaling and root planing (SRP), to control alveolar bone loss, bone metabolism regulation, and immune-inflammatory response to EP in rats submitted to chemotherapy with 5-FU.
Materials and methods

Animals
One hundred fifty adult male rats (Rattus norvegicus, albinus, Wistar) weighing between 200 and 300 g were used in this study. The experimental protocols (2011-01462) were approved by the Animal Experimentation Ethics Committee of the School of Dentistry of Araçatuba, Sao Paulo State University (UNESP).
Experimental periodontitis
The animals were anesthetized for all procedures by intramuscular injection of ketamine hydrochloride (70 mg/kg, Vetaset, Fort Dodge, IA, USA) and xylazine hydrochloride (6 mg/kg, Coopazine, Coopers, Sao Paulo, SP, Brazil). EP was induced using a cotton thread (#24, Linha Corrente, São Paulo, SP, Brazil) around the left mandibular first molars. The ligature was kept for 7 days in subgingival position by surgical knots [22] .
5-FU treatment
Systemic treatment with 5-fluorouracil (5-FU; 50 mg/ml; Eurofarma Laboratórios, Sao Paulo, SP, Brazil) was obtained through initial (80 mg/kg) and final (40 mg/kg, 48 h later) intraperitoneal injections [23, 24] .
Experimental groups
Seven days after EP induction, the ligature was removed and the animals were randomly separated, following a computerproduced chart in groups: EP (n = 30), no treatment; 5FU (n = 30), treated with 5-FU; 5FU/SRP (n = 30), treated with 5-FU, with SRP followed by irrigation with 1 ml of saline solution (SS); 5FU/SRP/LLLT (n = 30), treated with 5-FU, with SRP followed by irrigation with SS and LLLT; 5FU/ SRP/aPDT (n = 30), treated with 5-FU, with SRP, irrigation with 1 ml of methylene blue (MB) and LLLT.
SRP was carried out with mini-five manual currettes (#1-2 Hu-Friedy Co. Inc., Chicago, IL, USA) with ten traction movements in the distomesial direction in the vestibular and lingual faces of molars with EP. The interproximal and furcation areas [25] were scraped using the same currettes with traction movements in the cervical-occlusal direction. [20] . For aPDT, MB was used as a photosensitizer agent at 100 μg/ml concentration. Using an insulin syringe, 1 ml of MB was deposited in the dento-gingival area of the left mandibular first molar [20] . Sixty seconds after deposition of the photosensitizer, tissue radiation was carried out with laser following the same parameters described above.
LLLT and aPDT
Experimental periods
Ten animals of each group were submitted to euthanasia by injection of a lethal dose of 150 mg/kg thiopental (Cristália, Produtos Químicos Farmacêuticos Ltda., Itapira, SP, Brazil) at 7, 15, and 30 days after EP. The left hemimandibles were dissected and fixed in 4% formaldehyde in 0.1 M buffered solution, pH 7.4, for 48 h.
Processing for microscopic analysis
The specimens were submitted to demineralization in 10% ethylenediamine tetraacetic acid (EDTA) for 60 days. Subsequently, the specimens were processed by paraffin embedding and sectioned in a microtome (4 μm thickness). For the histological and histometric analyses, histological sections were submitted to hematoxylin-eosin (HE) staining. For the immunohistochemical analysis, the indirect immunoperoxidase technique was developed using antibodies to TRAP, RANKL, OPG, TNF-α, IL-6, and IL-10. The immunohistochemical processing followed the protocol described by Garcia et al. [26] .
Histological analysis
The histological analysis was performed by a certified histologist (EE), who was blinded to all experimental groups. The following parameters were evaluated: nature and degree of inflammation; extent of inflammatory process; presence and extent of tissue necrosis; presence, extent, and nature of bone resorption, cementum, and dentin; blood vessel characteristics; structuring pattern of extracellular matrix of periodontal tissues; and cellularity pattern of periodontal tissues [13] .
Histometric analysis
An imaging analysis system was used (Axiovision 4.8.2, Carl Zeiss MicroImaging GmbH, 07740 Jena, Germany) to measure the bone loss (BL) area in square millimeters in the furcation region. The BL of each specimen was measured three times at different days by the same examiner, who was calibrated and blinded to treatments (MLFA) in order to reduce data variation. The three obtained measurements were statistically evaluated by analysis of variance at 5% significance level. The means and standard deviations of absolute values were obtained, and data were compared by statistical analysis [21] .
Immunohistochemistry analysis
TRAP immunolabeling was analyzed by counting TRAPpositive cells located in the center of the interradicular septum of the left mandibular first molar of a 1000-μm × 1000-μm area, at ×200 magnification in three equidistant histological sections. The coronal limit of this area was the alveolar bone ridge, stretching apically along 1000 μm. Values were expressed as the number of multinucleated TRAP-positive osteoclasts [20] .
A semiquantitative analysis of the immunolabeling for RANKL and OPG was performed in the furcation area at ×400 magnification. The establishment of immunolabeling scores was based on Garcia et al., [13] . For TNF-α, IL-6, and IL-10, semiquantitative analysis was carried out in three slides per animal and the criterion used was that of Garcia et al. [26] .
Statistical analysis
The results of the calculations for sample size n (minimum) = 10 demonstrated a statistical power of 95% (p < 0.05). The analyses were performed using software (BioEstat-version 5.3, Instituto Mamirauá, Manaus, AM, Brazil) at 5% significance level. The normality of the histometric (BL) and immunohistochemical (TRAP) data was analyzed using the Shapiro-Wilk test. BL and TRAP intra-and intergroup analyses were carried out by analysis of variance (ANOVA). When ANOVA detected a statistically significant difference, multiple comparisons were performed using Tukey's post hoc test. The non-parametric KruskalWallis test was used to evaluate RANKL, OPG, IL-6, TNF-α, and IL10 score data. This test was followed by the non-parametric Student-Newman-Keuls test, when the Kruskal-Wallis test demonstrated significant difference.
Results
Histological analysis
An intense inflammatory infiltrate composed of neutrophils was present in the entire connective tissue of the furcation region in the EP group at 7 days. All specimens of this group presented necrotic bone spicules, surrounded by inflammatory cells in the furcation region. The interradicular septum showed a quite irregular outline and thin bone trabeculae, where a large number of active osteoclasts were observed on the surface (Fig. 1a, b) .
Inflammation was still very intense at 15 and 30 days. However, comparatively, there was a reduction in the volume occupied by the inflammatory infiltrate constituted of neutrophils and lymphocytes (Figs. 2a, b and 3a, b) . The connective tissue surrounding the interradicular septum was less inflamed. The interradicular septum showed thin bone trabeculae, with a quite irregular peripheral outline and active osteoclasts.
The connective tissue of the furcation area presented severe destruction of the extracellular matrix and moderate inflammatory infiltrate that reached the bone tissue of the interradicular septum in group 5FU at 7 and 15 days (Figs. 1c, d and 2c, d) . At 30 days, most of the specimens presented necrotic bone spicules, surrounded by inflammatory cells. The interradicular septum bone tissue was composed of very thin bone trabeculae, with extensive medullar spaces presenting inflammatory cells. The peripheral outline of the interradicular septum was very irregular, with many resorption gaps and active osteoclasts (Fig. 3c, d ).
There was a moderate inflammatory infiltrate occupying the connective tissue of the furcation area and bordering the bone tissue of the interradicular septum in group 5FU/SRP at 7 days. In most of the specimens, severe damage of the extracellular matrix was observed. Many necrotic bone spicules were present. The interradicular septum showed a quite irregular outline, with the presence of active osteoclasts and constituted of very thin bone trabeculae (Fig. 1e, f) . The volume occupied by the inflammatory infiltrate was progressively reduced at 15 and 30 days. The connective tissue surrounding the interradicular septum was significantly immature and inflamed, but it showed discreet repair signs, such as increase in the quantity of collagen fibers, fibroblasts, and blood vessels compared with 5FU. The bone trabeculae were still very thin, with a quite irregular surface, but with fewer osteoclasts and many active osteoblasts (Figs. 2e, f and 3e, f) .
Connective tissue with a narrow collagen fiber network, moderate quantity of fibroblasts, and moderate inflammatory infiltrate was observed in group 5FU/SRP/LLLT at 7 days. The interradicular septum was constituted of thin bone trabeculae, and the quantity of osteoclasts was moderate (Fig. 1g, h ). The histological characteristics at 15 days were similar to those described in the previous period; however, there was a reduction in the volume occupied by the inflammatory infiltrate and the tissues were more organized (Fig. 2g, h ). At 30 days, the connective tissue was composed of a large number of collagen fibers, with few fibroblasts and isolated focuses of inflammatory cells. The interradicular septum bone tissue was composed of thicker bone trabeculae, with few osteoclasts and many osteoblasts in activity (Fig. 3g, h) .
The connnective tissue showed a discreet number of inflammatory cells and a moderate number of collagen fibers and fibroblasts in group 5FU/SRP/aPDT at 7 days. The interradicular septum had thin bone trabeculae, with few osteoclasts in activity (Fig. 1i, j) . At 15 and 30 days, the connective tissue in the furcation region was composed of a large number of collagen fibers, few fibroblasts, and small isolated focuses of inflammatory cells. The bone trabeculae were thicker and not very irregular, with few osteoclasts and many active osteoblasts (Figs. 2i, j and 3i, j) . In some specimens, neoformed bone was observed in the most coronal portion of the interradicular septum.
Histometric analysis
The results are presented in Table 1 and demonstrated that there was significant smaller alveolar BL in the furcation area in the animals of group 5FU/SRP/aPDT compared with the animals of group 5FU in the 7-day evaluation period (p < 0.05). In the intragroup evaluation, there were no statistically significant differences in the evaluated periods (p > 0.05).
Immunohistochemical analysis
The immunoreactive cells presented a brownish color enclosed to the cytosolic compartment. For TRAP immunolabeling, a similar pattern prevailed in all groups and periods with no statistically significant difference (p > 0.05). TRAP-positive cells were multinucleated and located on the surface of the interradicular septum of the alveolar bone (Fig. 4a, d, g, j, m) .
The RANKL and OPG immunolabeling was predominantly expressed in osteoblasts and in some fibroblasts in the bone and connective tissue in the furcation region (Fig. 4b, c, Fig. 5a, d, g, j, m) .
IL-6 immunolabeling was predominantly expressed in inflammatory cells in some fibroblasts in the connective tissue in the furcation region. Regarding IL-6, no statistically significant differences were observed in the intragroup comparison. In the intergroup comparison, lower immunolabeling was noticed in group 5FU/SRP/aPDT when compared with group EP (p = 0.0100), 5FU (p = 0.0100), and 5FU/SRP (0.0100) at 7 days. Lower immunolabeling was also observed in groups 5FU/SRP/LLLT when compared with 5FU (p = 0.0100) and 5FU/SRP (p = 0.0394), as well as in group 5FU/SRP/aPDT when compared with groups EP (p = 0.0387), 5FU (p = 0.0019), and 5FU/SRP (p = 0.0098) at 15 days. Lower immunolabeling was also noticed in groups 5FU/SRP/LLLT (p = 0.0046) and 5FU/SRP/aPDT (p = 0.0046) when compared with group 5FU at 30 days (Fig. 5b, e, h, k, n) .
IL-10 immunolabeling was predominantly expressed in osteoblasts and fibroblasts situated in the bone and connective tissues in the furcation region, respectively. In the IL-10 intragroup analysis in group 5FU/SRP/aPDT, higher immunolabeling was observed at 30 days (p = 0.0295), compared with the 7-day period. In the intergroup comparison, higher immunolabeling was noticed in group 5FU/SRP/aPDT when compared with groups EP (p = 0.0295), 5FU (p = 0.0295), and 5FU/SRP at 30 days (p = 0.0295; Fig. 5c, f, i, l, o) . 
Discussion
It has been demonstrated that chemotherapy with 5-FU promotes leucopenia in animals [13, 27] , increasing the vulnerability of the host to periodontal diseases [6] . The histological analysis demonstrated that EP in animals treated with 5-FU was more severe, prevailing damage and disorganization of all periodontal tissues, and significant necrotic bone spicules and intense inflammatory infiltrate. However, despite the increase of BL at 7 and 15 days in the animals of group 5FU, there was no statistically significant difference with groups EP, 5FU/ SRP, and 5FU/SRP/LLLT. These data demonstrate that 5-FU aggravated the severity of EP, similar to those in studies showing severe alveolar bone damage in rats with EP and submitted to chemotherapy with cyclophosphamide [28, 29] . These findings are also corroborated by another study where lower bone percentage was observed, with large necrotic bone areas [13] including nearly the totality of the bone in the furcation region in animals submitted to 5-FU chemotherapy. 5-FU induces alterations in the keratinocytes of the oral epithelium [30] via an autophagic degeneration process, affects the local immune response by promoting morphological alterations of the epithelium [31] , and significantly reduces the number of osteoblasts of the trabecular surface [32] . Besides in animals treated with aPDT (5FU/SRP/aPDT group), there were significant smaller alveolar BL in the furcation area compared with animals of group 5FU in the 7-day evaluation period. On the other hand, the histological analysis of animals in groups 5FU/SRP/LLLT and 5FU/ SRP/aPDT revealed connective tissue with a narrow collagen fiber network, a moderate amount of fibroblasts, and moderate inflammatory infiltrate and the interradicular septum was constituted of fine bone trabeculae, with few osteoclasts in the 7-day period. However, most of the animals of the other groups, submitted to chemotherapy (5FU and 5FU/ SRP) and no adjuvant treatments, demonstrated severe damage of the extracellular matrix and presence of many necrotic bone spicules.
These results demonstrated that LLLT and PDT reduced the process of bone tissue damage and local inflammation, favoring the repair process, thus corroborating the findings of other studies in systemically modified animals [17] [18] [19] [20] . The effects of LLLT may have biostimulated epithelial migration and organization of the connective tissue [18, 33] , favoring tissue and bone repair. In this study, lower TNF-α and Il-6 immunolabeling was observed in animals treated with LLLT and aPDT, demonstrating that both evaluated adjuvant therapies were effective in the reduction of these pro-inflammatory biomarkers. The reduction in the levels of these proinflammatory cytokines, in animals treated with LLLT and aPDT, may have interfered in the reduction of the bone damage process that is aggravated by chemotherapy [34] .
One possible limitation of this study is lack of a phenotiazinium-photosensitizer-alone treatment group. This fact is justified because several studies of our group did not show significant improvement of periodontitis using phenotiazinium photosensitizers alone in rats [17, 19, 22, 25] . On the other hand, a recent study of our group demonstrated that the combination of multiple LLLT sessions improved inflammation and reduced the destruction of periodontal tissue, worsened by chemotherapy, although it did not reduce periodontopathogenic bacteria of periodontitis areas in rats [21] .
Regarding the effects of aPDT, it has been demonstrated that this therapy is able to reduce inflammatory cytokines like IL-1β and TNF-α [35, 36] . The reduction of proinflammatory biomarkers in this study in animals treated with LLLT and aPDT can be associated with higher reduction of RANKL expression in the 7-and 15-day periods. On the other hand, there were no statistical differences regarding the presence of TRAP-or OPG-positive cells among the evaluated groups. Regarding IL-10 immunolabeling, which is associated with inhibition of bone resorption [37] , there was higher immunolabeling in group 5FU/SRP/aPDT compared with groups EP, 5FU, and 5FU/SRP. This finding might be justified by the highest reduction of periodontopathogens in animals treated with aPDT [38] , which would reduce the release of pro-inflammatory cytokines, regulating bone metabolism and minimizing the immuno-inflammatory response. Although both evaluated therapies seem effective in the control of EP, further studies are needed to assess the effects of the protocols of these therapies for periodontal treatment in patients under chemotherapy.
Conclusion
Based on the present results, it is possible to conclude that 5-FU aggravated the progression of EP. In addition, LLLT and aPDT were effective adjuvant therapies to SRP, minimizing the side effects caused by 5-FU in periodontal disease. Finally, aPDT promoted significant benefits in the control of alveolar bone loss and immuno-inflammatory response.
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